Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report.
Batts
D H
DH
Infectious Diseases, Medical Affairs, Pharmacia, Kalamazoo, Michigan, USA.
Lavin
B S
BS
Eliopoulos
G M
GM
D000081:Acetamides / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019540:Area Under Curve; D002648:Child; D003428:Cross Infection / Q000188:drug therapy*; D004338:Drug Combinations; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D000069349:Linezolid; D008826:Microbial Sensitivity Tests; D023303:Oxazolidinones / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014018:Tissue Distribution; D014769:Virginiamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000081:Acetamides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004338:Drug Combinations; D023303:Oxazolidinones; D014769:Virginiamycin; C113825:quinupristin; D000069349:Linezolid; C113826:dalfopristin